Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Company management will be participating tomorrow.

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron Apr 20, 2023 12:14pm

198 Views

Post# 35405452

RE:RE:RE:RE:RE:Company management will be participating tomorrow.

@inthno. Message on my home phone 4/18/23. MC identified himself, encouraged shareholders to vote. Mentioned directors, auditors and options. Explained how to vote et cetera. The message was 75 seconds in duration and came from 877 452 7184. I am a very small shareholder and the message was for all shareholders regardless of the number of shares held.

I considered the message useful and expect others will receive it. I have nothing further to say on the matter.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market